NYSE:ZOM - Zomedica Pharmaceuticals Corp (NYSEAMERICAN) Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.25 +0.01 (+0.45 %)
(As of 07/16/2018 04:49 AM ET)
Previous Close$2.25
Today's Range$2.22 - $2.27
52-Week Range$1.64 - $2.98
Volume26,693 shs
Average Volume299,887 shs
Market Capitalization$212.65 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs. It is also developing ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. The company has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. Zomedica Pharmaceuticals Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Receive ZOM News and Ratings via Email

Sign-up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNYSE:ZOM
CUSIPN/A
Phone734-369-2555

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees20
Outstanding Shares94,510,000
Market Cap$212.65

The Truth About Cryptocurrencies

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) Frequently Asked Questions

What is Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s stock symbol?

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZOM."

How were Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s earnings last quarter?

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) issued its quarterly earnings results on Tuesday, May, 15th. The company reported ($0.02) EPS for the quarter. View Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s Earnings History.

When is Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s next earnings date?

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) is scheduled to release their next quarterly earnings announcement on Tuesday, August, 21st 2018. View Earnings Estimates for Zomedica Pharmaceuticals Corp (NYSEAMERICAN).

What is the consensus analysts' recommendation for Zomedica Pharmaceuticals Corp (NYSEAMERICAN)?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zomedica Pharmaceuticals Corp (NYSEAMERICAN) in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Are investors shorting Zomedica Pharmaceuticals Corp (NYSEAMERICAN)?

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) saw a increase in short interest in June. As of June 29th, there was short interest totalling 1,409,434 shares, an increase of 5,154.6% from the June 15th total of 26,823 shares. Based on an average trading volume of 572,273 shares, the days-to-cover ratio is presently 2.5 days. Currently, 3.5% of the shares of the company are sold short. View Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s Current Options Chain.

Who are some of Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s key competitors?

Who are Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s key executives?

Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s management team includes the folowing people:
  • Mr. Gerald L. Solensky Jr., Chairman, CEO & Pres (Age 44)
  • Dr. Stephanie Morley DVM, COO & VP of Product Devel. (Age 43)
  • Mr. Robert W. DiMarzo, Exec. VP of Global Strategy (Age 61)
  • Mr. Shameze Rampertab B.Sc. MBA, CA, CPA, CFO, Corp. Sec. & Director (Age 51)
  • Mr. Bruk Herbst, Chief Commercial Officer (Age 49)

Has Zomedica Pharmaceuticals Corp (NYSEAMERICAN) been receiving favorable news coverage?

Headlines about ZOM stock have been trending somewhat positive on Monday, Accern Sentiment reports. Accern ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) earned a coverage optimism score of 0.08 on Accern's scale. They also gave news articles about the company an impact score of 45.21 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Zomedica Pharmaceuticals Corp (NYSEAMERICAN)?

Shares of ZOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s stock price today?

One share of ZOM stock can currently be purchased for approximately $2.25.

How big of a company is Zomedica Pharmaceuticals Corp (NYSEAMERICAN)?

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) has a market capitalization of $212.65 million. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) employs 20 workers across the globe.

How can I contact Zomedica Pharmaceuticals Corp (NYSEAMERICAN)?

Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s mailing address is 3928 VARSITY DRIVE, ANN ARBOR MI, 48108. The company can be reached via phone at 734-369-2555.


MarketBeat Community Rating for Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE ZOM)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  12
MarketBeat's community ratings are surveys of what our community members think about Zomedica Pharmaceuticals Corp (NYSEAMERICAN) and other stocks. Vote "Outperform" if you believe ZOM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZOM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.